Author

Fei Huang

University of ChicagoORCID 0000-0001-6201-5185Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Fei Huang1 paper · University of Chicago

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1 Organism:zebrafish· 1

Frequent Co-Authors

Abhishek KulkarniiD· 1 shared Advaita Chakraborty· 1 shared Bernhard Maier· 1 shared Cara M. Anderson· 1 shared Dawei WangiD· 1 shared Haiping HaoiD· 1 shared Jiayu DingiD· 1 shared Jinxin Jiang· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Abhishek KulkarniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyJournal of Biological ChemistryPeer-reviewedJan 18, 2025

Hypusinated and unhypusinated isoforms of eIF5A exert distinct effects in models of pancreas development and function

Cara M. Anderson, Abhishek Kulkarni, Bernhard Maier…·Raghavendra G. Mirmira

This study investigates the distinct roles of hypusinated and unhypusinated eIF5A isoforms in pancreas development and function using zebrafish and mouse models.

6 citationstop 5%

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 7, 2024

Targeting protein tyrosine phosphatase non-receptor type 2 with a novel inhibitor for AML therapy

Wenbin Kuang, Jinxin Jiang, Xiao Wang…·Peng Yang

This study identifies PTPN2 as a therapeutic target in AML, discovers a selective inhibitor K73, and demonstrates its efficacy in reducing AML burden in vitro and in vivo.

2 citations

humanexperimental assay

𝕏 PostBluesky